Relmada Therapeutics Receives Health Canada Clearance to Commence First Clinical Study of d-Methadone

By WebmasterDecember 1, 2014November 1st, 2024No Comments

Relmada Therapeutics Receives Health Canada Clearance to Commence First Clinical Study of d-Methadone
Read more here

Previous PostMelior Discovery Awarded SBIR Grant for Studying MLR-1023 Mechanism of Action
Next PostNovira Therapeutics Announces Presentation of Phase Ia Safety and Pharmacokinetic Data for NVR 3-778